This website uses cookies to enhance your browsing experience. By continuing to use this site, you consent to the use of cookies. Please review our Privacy Policy for more information on how we handle your data.
Apple is using its newest AirPods Pro as a way to help break into the health ind...
The data sets the stage for likely approval of Gilead's Lenacapavir for HIV prev...
Moderna is deprioritizing certain parts of its pipeline, which involves pausing ...
Deep vein thrombosis can be a serious health issue that strikes at any time. But...
Safi Biotherapeutics, a government-backed startup, is growing blood in a lab to ...
A large swath of insured Americans could be eligible for a popular class of weig...
AstraZeneca shares fell more than 5% Tuesday morning, the biggest one-day drop i...
Leqembi's rollout has been slowed by bottlenecks related to reimbursement uncert...
Abbott Laboratories announced Lingo, its first over-the-counter continuous gluco...
Eli Lilly could be on its way to topping $1 trillion in market value. Meanwhile,...
Every weekday, the Investing Club releases the Homestretch; an actionable aftern...
Epic Systems, a 45-year-old health-care software company, remains privately held...
A brand new round of Covid shots from Pfizer and Moderna is about to reach Ameri...
Dexcom launched its continuous glucose monitor called Stelo on Monday, which is ...
Here's what we know about the latest mpox outbreak.